Low-T Therapy Increases Risk of Heart Attack
Low testosterone therapy, more commonly referred to as “Low-T” therapy, has been making headlines recently as doctors and pharmaceutical companies have championed the products as a miracle cure for fatigue, weakness, depression, erectile dysfunction, and loss of sex drive. These symptoms are the result of a natural and gradual decrease in testosterone levels in the body as men age. To combat these natural signs of aging, many have sought the benefits of Low-T therapy. Testosterone therapy has also become popular among younger men who are looking to enhance physical performance in sports or even sexual performance. But at what cost?
Low-T therapy was designed to reverse or slow down the effects of hypogonadism, the condition that occurs when the body fails to create enough natural hormones due to problems arising from the testicles or the pituitary glands. Low-T therapy, also known as androgen replacement therapy, uses bioidentical or synthetic hormones to replace those hormones that the body is lacking. For many men, Low-T has been successful at increasing their testosterone levels and allowing the symptoms of fatigue, depression, muscle weakness, and low sex drive to subside. Several doctors prefer Low-T therapy over medications such as Viagra when treating erectile dysfunction. Men using the hormones to increase athletic performance have reported a successful increase in muscle mass as well.
Numerous others, however, have reported serious and sometimes deadly side effects from the therapy such as blood clots, stroke, and heart attacks. As a result, several studies have been conducted on the effects of testosterone replacement therapy. One such study reported that generally healthy men over the age of 60 and men under the age of 60 with a history of heart disease had more than two times the risk of heart attack within the first 90 days of treatment. This year the FDA issued a safety announcement highlighting possible side-effects from testosterone products as well as emphasizing their approval of its use only in males with medical conditions which prevent the natural production of testosterone.
This past June, 44 lawsuits against testosterone replacement manufacturers were sent for hearing to the U.S. District Court for the Northern District of Illinois. These lawsuits claim that the manufacturers of Low-T pharmaceutical drugs failed to properly warn consumers of the serious and sometimes fatal risks associated with use of these products. They also argue that the manufacturers used misleading marketing strategies to imply the safe use of the drugs to treat more than just hypogonadism. The manufacturers currently involved include Abbott, Abbvie, Auxilium Pharmaceuticals, Pfizer, and Pharmacia Upjohn. As more reports of adverse side-effects come to light, the number of lawsuits against these companies is expected to reach the thousands.
The risks associated with Low-T therapy drugs are dangerous and can be life-threatening. If you or someone you know has been affected by Low-T therapy, you may have a case for product liability. Please call our Nashville injury attorneys at (615) 244-2222. Schedule your free evaluation of your potential case for more information.